Location of Repository

Gestational trophoblastic neoplasm and women living with HIV and/or AIDS

By Pieter Barnardt and Martha Relling

Abstract

<p>The 2011 World Health Organization global report on HIV and/or AIDS estimated that sub-Saharan Africa comprised 67% of the global HIV burden, with a current estimate of 5.9 million cases in South Africa. Since the introduction of antiretroviral therapy, there has been an increase in the incidence of non-AIDS-defining cancers. Gestational trophoblastic neoplasm (GTN) is a rare pregnancy-related disorder with an incidence ranging from 0.12–0.7/1000 pregnancies in Western nations. The overall cure rate is about 90%. Response to treatment for GTN is generally favourable; but the sequelae of HIV and/or AIDS, the resultant low CD4 counts, comorbidities, poor performance status and the extent of metastatic disease in patients receiving chemotherapy, compromise the prognosis and survival.</p

Topics: Gestational Trophoblastic Neoplasm (GTN), HIV/AIDS, Choriocarcinoma, Chemotherapy, Public aspects of medicine, RA1-1270
Publisher: AOSIS
Year: 2015
DOI identifier: 10.4102/sajhivmed.v16i1.344
OAI identifier: oai:doaj.org/article:775dec43cb9646019e22d5ecdfb2eda3
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/2078-6751 (external link)
  • https://doaj.org/toc/1608-9693 (external link)
  • http://www.sajhivmed.org.za/in... (external link)
  • https://doaj.org/article/775de... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.